Overexpression of the 5-Hydroxytryptamine Transporter Gene
- 4 May 2004
- journal article
- Published by Wolters Kluwer Health in Circulation
- Vol. 109 (17), 2150-2155
- https://doi.org/10.1161/01.cir.0000127375.56172.92
Abstract
Background— Increased serotonin (5-hydroxytryptamine, 5-HT) transporter activity has been observed in human familial pulmonary hypertension.Keywords
This publication has 22 references indexed in Scilit:
- Serotonin Transporter Inhibitors Protect against Hypoxic Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Rat strain differences in peripheral and central serotonin transporter protein expression and functionEuropean Journal of Neuroscience, 2003
- Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertensionJournal of Clinical Investigation, 2001
- Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta familyJournal of Medical Genetics, 2000
- 5‐hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertensionBritish Journal of Pharmacology, 2000
- Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter geneJournal of Clinical Investigation, 2000
- Refined mapping of the human serotonin transporter (SLC6A4) gene within 17q11 adjacent to the CPD and NF1 genesEuropean Journal of Human Genetics, 2000
- Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory RegionScience, 1996
- 5‐Hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive ratsBritish Journal of Pharmacology, 1996
- [3H]Citalopram Binding to Brain and Platelet Membranes of Human and RatJournal of Neurochemistry, 1991